Agnete Fredriksen
Company: Nykode Therapeutics
Job title: Chief Scientific Officer
Seminars:
Utilizing a Modality-Agnostic Platform for a Head-to-Head Comparison of mRNA & DNA-based Personalized Cancer Vaccines in Creating an Immune Response 2:00 pm
Comparing DNA and mRNA as modalities to encode for fusion proteins in individualized cancer vaccines to effectively induce an immune response Utilizing a unique bioinformatics platform to target immunogenic APCs in personalized cancer vaccines for better tumor control Exploring DNA-based personalized cancer vaccines that produce differentiated and more effective T-cellsRead more
day: Conference Day One
Panel Discussion:Examining the Route of Personalized Cancer Vaccines From a Range of Modalities Through the Clinic to Get Effective Therapies to Patients Faster 9:30 am
Uncovering how successful trials are in selecting patients and achieving clinical efficacy Understanding the importance of durability and half-life of vaccines in patients for a swift journey through the clinic Navigating the regulatory frameworks for personalized medicine to ensure success post-approvalRead more
day: Conference Day Two